Syllabus2017

Controversies 2017 Online Syllabus

Take the 2017 course evaluation

General Course Materials

Updated 2017 scientific program

PDFs of the faculty presentations will be available below, when approved by the speaker.

To the best of our ability, PDFs will be posted within 24 hours of presentation.

Thursday, November 16, 2017

Welcome Address - John Harold, MD

Welcome Address from CA ACC - Garwood Gee

How Can We Dislodge CAD as the Nation's #1 Killer? - James Forrester, MD

Session I: Atherosclerosis and Dyslipidemia

PCSK9 Inhibitors - Michael Blaha, MD, MPH

Targeting Inflammation in Atherosclerosis - Sanjay Kaul, MD, MPH

Session II: California Chapter ACC Statellite Symposium: Innovation and Technology

Advances in Digital Medicine - Raj Khandwalla, MD, MA

ACC Innovation - John Harold, MD

Everyone's a Critic - Bill Tancer

The APP-lication of Innovation and Technology - Vinayak Bapat, FRCS, CTh

Session III: STEMI, NSTEMI, Cardiac Arrest

Case Presentation - Sam Dawkins, MD, PhD

Case Presentation - Richard Cheng, MD

New Horizons in Cardiogenic Shock - Timothy D. Henry, MD

YES, We Need EKG Transmission - Ivan C. Rokos, MD

NO, EKG is Not Necessary - Timothy D. Henry, MD

New Horizons in Cardiogenic Shock - Timothy D. Henry, MD

Session IV: Contemporary Controversies in Drugs and Devices

COMPASS Trial - C. Michael Gibson, MD

Does IMPROVE-IT and FOURIER Confirm or Refute the LDL Hypothesis? - Sanjay Kaul, MD, MPH

Session V: Controversies in Advanced Heart Failure

Diastolic Function: Progress in the Treatment of Cardiac Amyloid - Jignesh Patel, MD, PhD

Medical Treatment for Restrictive Cardiomyopathy - Dael Geft, MD

Surgical Treatment for Restrictive Cardiomyopathy - Danny Ramzy, MD, PhD

Session VI: Hypertension

Rise, Fall, and Resurrection of Renal Denervation - Michael A. Weber, MD

Friday, November 17, 2017

Session VII: Electrophysiology

Sudden Death in Athletes - Jacob Tfelt-Hansen, MD, DMSc

Catheter Ablation for Atrial Fibrillation - Francis Marchlinski, MD

His Bundle Pacing - Kenneth Ellenbogen, MD

ICDs for Non-Ischemic Cardiomyopathy - Win Shen, MD

The Cedars-Sinai Heart Institute: A Ten Year Progress Report - Eduardo Marban, MD, PhD

Session VIII: Sex Differences in CVD - Drug and Device Approval and Use

Introduction and Overview - C. Noel Bairey Merz, MD

Example of Sex Differences of Clinical Importance - Viviany Taqueti, MD, MPH

Considerations of Sex Differences in FDA Device Approval - Teri L. Cornelison, MD, PhD

Overview of FDA Review, Approval, Post-Approval Monitoring - Marjorie Jenkins, MD, MEdHP

Session IX: Controversies in Structural Heart Disease

PFO Closure - Ted Feldman, MD

Is It Time for a National Network of Valve Centers? - Michael Mack, MD

What Degree of MR Deserves Surgical or Transcatheter Intervetion - Robert Siegel, MD

Session X: Update in Cardiac Imaging

Coronary Calcium Scan - Matthew Budoff, MD

Coronary CTA - Gilbert Raff, MD

HFPEF - ECHO with Strain vs. MRI T1 Mapping - Erik Schelbert, MD, MS

FFR is NOT the Gold Standard for Revascularization Decision Making - Paul S. Teirstein, MD

FFR IS the Gold Standard for Revascularization Decision Making - Matthew J. Price, MD

Update in Nuclear Imaging of Infiltrative Cardiomyopathy - Balaji Tamarappoo, MD, PhD

Stress SPECT/PET vs. Stress ECHO - Sean Hayes, MD

Stress SPECT/PET vs. Stress ECHO - Charles Pollick, MD

FFR-CT: Not Ready for Prime Time - Leslee Shaw, PhD

Intermediate Lesion on CCTA - Jonathon A. Leipsic, MD